1. Gent M, Blakely JA, Easton JD, Ellis DJ, Hachinski VC, Harbison JW, Panak E, Roberts RS, Sicurella J, Turpie AG: The Canadian American Ticlopidine Study (CATS) in the thromboembolic stroke. Lancet. 1989, 1: 1215-1220. 10.1016/S0140-6736(89)92327-1.
2. Hass WK, Easton JD, Adams HP, Pryse-Phillips W, Molony BA, Anderson S, Kamm B: A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. N Engl J Med. 1989, 321: 501-507. 10.1056/NEJM198908243210804.
3. SPREAD Stroke Prevention And Educational Awerness Diffusion - V Edizione 2007 - Ictus cerebrale: linee guida italiane di prevenzione e trattamento, 319.
4. Paradiso-Hardy F, Angelo MC, Lanctot KL, Cohen EA: Hematologic dyscrasia associated with ticlopidine therapy: evidence for casuality. CMAJ. 2000, 163: 1441-1448.
5. Grieco A, Vecchio FM, Greco AV, Gasbarrini G: Cholestatic hepatitis due to ticlopidine: clinical and histological recovery after drug withdrawal. Case report and review of the literature. Eur J Gastroenterol Hepatol. 1998, 10: 713-715.